Research Paper Volume 15, Issue 11 pp 4926—4948
The potential of FCRL genes as targets for cancer treatment: insights from bioinformatics and immunology
Figure 6. GESA for DEGs of high- and low-FCRL1 group in different cancer types. (A) BRCA, (B) CESC, (C) HNSC, (D) LIHC, (E) LUAD, (F) READ, (G) SARC, (H) SKCM.